Skip to content
Search

Latest Stories

Competition watchdog says PCR testing market needs more regulation

The UK's competition watchdog has advised the government to implement greater regulation on the PCR Covid testing market amid fears that competition alone “will not deliver the right outcomes for consumers”.

The Competition and Markets Authority (CMA) highlighted the risk of a “race to the bottom”, in which testing firms could begin to compete on grounds other than quality with travellers ending up losing out.


Earlier, consumers had complained against the test providers about high charges and poor service. Complainants even said that some providers did not pay refunds and became inaccessible when things went wrong.

The average cost of such a test is £93 in the UK, far higher than in many European countries.

Besides advising the government on the matter, the CMA is already using its powers to act where it can. On August 25, it published an open letter to all PCR test providers warning them to adhere to the consumer law.

Later on September 3, it opened a formal investigation into Expert Medicals, one of the largest providers in the market. It is also considering to launch probe into other companies.

Meanwhile, the CMA review found that “combination of up-front regulation, monitoring and wider sanctions is needed” to deliver right outcome for consumers.

It recommended that the government should create a list of quality providers by “significantly improving the basic standards to qualify for inclusion”.

In addition, an enhanced monitoring system should be brought in to keep track of providers and quickly remove those which fall short of standards.

CMA chief executive Andrea Coscelli said the market needs a “more interventionist approach” backed by monitoring and enforcement to protect consumers.

“Buying a PCR travel test is a lottery. From complaints about dodgy pricing practices, to unfair terms, to failure to provide tests on time or at all, to problems with getting refunds, the experience for some is just not good enough."

Health secretary Sajid Javid said the government has removed 91 providers from Gov.uk and corrected inaccurate prices of 135 private providers, who will be removed from the list if they advertise misleading prices again.

Further, to ensure travel test providers perform as per law, from September 21, “there will be tough new penalties for companies that fail to follow the law, including fixed fines of up to £10,000.”

Javid added: “I am reviewing the recommendations from the Competition and Markets Authority and will outline further changes shortly to ensure consumers are given the best tests at the very best prices.”

More For You

 RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care

Professor Tony Avery OBE

Pic credit: RPS

Professor Tony Avery OBE awarded RPS Honorary Fellowship

The Royal Pharmaceutical Society (RPS) Assembly has awarded an Honorary Fellowship to Professor Tony Avery OBE in recognition of his outstanding contribution to prescribing safety and patient care.

The Honorary Fellowship is given to those who are not eligible for membership of the Society but have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.

Keep ReadingShow less
US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less